B. J. Maron, J. M. Gardin, J. M. Flack, S. S. Gidding, T. T. Kurosaki-&-d et al., Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults, Circulation, vol.92, pp.785-794, 1995.

B. J. Maron and . Braunwald, Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease, Circulation, vol.126, pp.1640-1644, 2012.

D. Teare, Asymmetrical hypertrophy of the heart in young adults, Br Heart J, vol.20, pp.1-8, 1958.

B. J. Maron, P. Spirito, W. K. Shen, T. S. Haas, F. Formisano et al., Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy, JAMA, vol.298, pp.405-417, 2007.

C. O'mahony, F. Jichi, M. Pavlou, L. Monserrat, A. Anastasakis et al., Hypertrophic Cardiomyopathy Outcomes (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD), Eur Heart J, vol.35, pp.2010-2030

C. O'mahony, M. Tome-esteban, P. D. Lambiase, A. Pantazis, S. Dickie et al., A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy, Heart, vol.99, pp.534-575, 2013.

B. J. Maron, Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy, Circulation, vol.121, pp.445-56, 2010.

B. J. Maron, E. J. Rowin, S. A. Casey, T. S. Haas, R. H. Chan et al., Risk stratification and outcome of patients with hypertrophic cardiomyopathy ³ 60 years of age, Circulation, vol.127, pp.585-93, 2013.

S. R. Ommen, B. J. Maron, I. Olivotto, M. S. Maron, F. Cecchi et al., Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.46, pp.470-476, 2005.

B. J. Maron, Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy, Circulation, vol.116, pp.196-206, 2007.

B. J. Maron, S. R. Ommen, R. A. Nishimura, and &. A. Dearani, Myths about surgical myectomy: rumors of its death have been greatly exaggerated, Am J Cardiol, vol.101, pp.887-896, 2008.

B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, H. V. Schaff et al., The case for surgery in obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.44, pp.2044-53, 2004.

S. F. Nagueh, B. M. Groves, L. Schwartz, K. M. Smith, A. Wang et al., Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry, J Am Coll Cardiol, vol.58, pp.2322-2330, 2011.

A. Iacovoni, P. Spirito, C. Simon, M. Iascone, G. D. Dedda et al., A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy, Eur Heart J, vol.33, pp.2080-2087, 2012.

K. M. Harris, P. Spirito, M. S. Maron, A. G. Zenovich, F. Formisano et al., ) Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy, Circulation, vol.114, pp.216-241, 2006.

M. S. Maron, B. M. Kalsmith, J. E. Udelson, W. Li, and &. Denofrio, Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy, Circ Heart Fail, vol.3, pp.574-583, 2010.

Y. M. Cha, B. J. Gersh, B. J. Maron, G. Boriani, P. Spirito et al., Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy, J Cardiovasc Electrophysiol, vol.18, pp.483-490, 2007.

D. Donna, P. , I. Olivotto, S. D. Delcre, D. Caponi et al., Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression, Europace, vol.12, pp.347-55, 2010.

R. H. Chan, B. J. Maron, I. Olivotto, M. J. Pencina, G. E. Assenza et al., Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy, Circulation, vol.130, pp.484-95, 2014.

T. F. Haland, V. M. Almaas, N. E. Hasselberg, J. Saberniak, I. S. Leren et al., Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy, Eur Heart J Cardiovasc Imaging, vol.17, pp.613-634, 2016.

M. Saito, H. Okayama, T. Yoshii, H. Higashi, H. Morioka et al., Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy, Eur Heart J Cardiovasc Imaging, vol.13, pp.617-640, 2012.

B. J. Maron, Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy, Circulation, vol.109, issue.8, pp.984-989, 2004.

C. Lio, K. Inoue, K. Nishimura, A. Fujii, T. Nagai et al., Characteristics of Left Atrial Deformation Parameters and Their Prognostic Impact in Patients with Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking Echocardiography, Echocardiography, vol.32, pp.1821-1851, 2015.

B. J. Maron and . Maron, The Remarkable 50 Years of Imaging in HCM and How it Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR, JACC Cardiovasc Imaging, vol.9, pp.858-872, 2016.

M. Garcia-castro, E. Coto, J. R. Reguero, J. R. Berrazueta, V. Alvarez et al., Rev Esp Cardiol, vol.62, pp.48-56, 2009.

P. M. Elliott, J. Poloniecki, S. Dickie, S. Sharma, L. Monserrat et al., Sudden death in hypertrophic cardiomyopathy: identification of high risk patients, J Am Coll Cardiol, vol.36, pp.2212-2220, 2000.

B. J. Maron, P. Spirito, W. K. Shen, T. S. Haas, F. Formisano et al., Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy, JAMA, vol.298, pp.405-417, 2007.

B. J. Maron, E. J. Rowin, S. A. Casey, M. S. Link, J. R. Lesser et al., Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies, J Am Coll Cardiol, vol.65, pp.1915-1943, 2015.

I. Olivotto, R. Gistri, P. Petrone, E. Pedemonte, D. Vargiu et al., Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.41, pp.315-336, 2003.

L. Monserrat, P. M. Elliott, J. R. Gimeno, S. Sharma, M. Penas-lado et al., Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients, J Am Coll Cardiol, vol.42, pp.873-882, 2003.

M. S. Maron, I. Olivotto, S. Betocchi, S. A. Casey, J. R. Lesser et al., Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy, N Engl J Med, vol.348, pp.295-303, 2003.

A. S. Adabag, S. A. Casey, M. A. Kuskowski, A. G. Zenovich-&-b, and . Maron, Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.45, pp.697-704, 2005.

J. R. Gimeno, M. Tome-esteban, C. Lofiego, J. Hurtado, A. Pantazis et al., Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy, Eur Heart J, vol.30, pp.2599-605, 2009.

G. K. Efthimiadis, D. G. Parcharidou, G. Giannakoulas, E. D. Pagourelias, P. Charalampidis et al., Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy, Am J Cardiol, vol.104, pp.695-704, 2009.

S. Maki, H. Ikeda, A. Muro, N. Yoshida, A. Shibata et al., Predictors of sudden cardiac death in hypertrophic cardiomyopathy, Am J Cardiol, vol.82, pp.774-782, 1998.

P. Elliott, J. Gimeno, M. Tome, and &. Mckenna, Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy, Eur Heart J, vol.27, p.3073, 2006.

A. D'andrea, P. Caso, S. Severino, S. Cuomo, G. Capozzi et al., Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy, Eur Heart J, vol.27, pp.1311-1319, 2006.

M. J. Kofflard, F. J. Cate, C. Van-der-lee, and &. R. Van-domburg, Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration, J Am Coll Cardiol, vol.41, pp.987-93, 2003.

P. Spirito, C. Autore, C. Rapezzi, P. Bernabo, R. Badagliacca et al., Syncope and risk of sudden death in hypertrophic cardiomyopathy, Circulation, vol.119, pp.1703-1713, 2009.

R. M. Lang, L. P. Badano, V. Mor-avi, J. Afilalo, A. Armstrong et al., Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, vol.16, pp.233-70, 2015.

P. Spirito, P. Bellone, K. M. Harris, P. Bernabo, P. &. Bruzzi et al., Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy, N Engl J Med, vol.342, pp.1778-85, 2000.

P. M. Elliott, J. R. Blanes, N. G. Mahon, J. D. Poloniecki-&-w, and . Mckenna, Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy, Lancet, vol.357, pp.420-424, 2001.

C. Autore, P. Bernabo, C. S. Barilla, P. Bruzzi, and &. Spirito, The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms, J Am Coll Cardiol, vol.45, pp.1076-80, 2005.

Z. Sasson, P. G. Yock, L. K. Hatle, E. L. Alderman-&-r, and . Popp, Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.11, pp.752-758, 1988.

B. J. Maron, N. A. Estes, M. S. Maron, A. K. Almquist, M. S. Link et al., Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy, Circulation, vol.107, pp.2872-2877, 2003.

S. F. Nagueh, C. P. Appleton, T. C. Gillebert, P. N. Marino, J. K. Oh et al., Recommendations for the evaluation of left ventricular diastolic function by echocardiography, J Am Soc Echocardiogr, vol.22, pp.107-140, 2009.

P. Lancellotti, C. Tribouilloy, A. Hagendorff, B. A. Popescu, T. Edvardsen et al., Zamorano & I. Scientific Document Committee of the European Association of Cardiovascular (2013) Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, vol.14, pp.611-655

R. A. Nishimura, C. M. Otto, R. O. Bonow, B. A. Carabello, J. P. Erwin et al., AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, C. American College of, A. American College of Cardiology/American Heart & A. American Heart, vol.148, pp.1-132, 2014.

M. Cameli, M. Caputo, S. Mondillo, P. Ballo, E. Palmerini et al., Feasibility and reference values of left atrial longitudinal strain imaging by two-dimensional speckle tracking, Cardiovasc Ultrasound, vol.7, p.6, 2009.

L. Sanchis, L. Gabrielli, R. Andrea, C. Falces, N. Duchateau et al., Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction, Eur Heart J Cardiovasc Imaging, vol.16, pp.62-69, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02282410

M. C. Todaro, I. Choudhuri, M. Belohlavek, A. Jahangir, S. Carerj et al., New echocardiographic techniques for evaluation of left atrial mechanics, Eur Heart J Cardiovasc Imaging, vol.13, pp.973-84, 2012.

B. J. Maron, S. A. Casey, R. H. Chan, R. F. Garberich, E. J. Rowin-&-m et al., Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy, Am J Cardiol, vol.116, pp.757-64, 2015.

P. M. Elliott, A. Anastasakis, M. A. Borger, M. Borggrefe, F. Cecchi et al., ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur Heart J, vol.35, pp.2733-79, 2014.

P. Spirito, C. Autore, F. Formisano, G. E. Assenza, E. Biagini et al., Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors, Am J Cardiol, vol.113, pp.1550-1555, 2014.

J. C. Moon, W. J. Mckenna, J. A. Mccrohon, P. M. Elliott, G. C. Smith-&-d et al., Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance, J Am Coll Cardiol, vol.41, pp.1561-1568, 2003.

J. A. Mccrohon, J. C. Moon, S. K. Prasad, W. J. Mckenna, C. H. Lorenz et al., Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance, Circulation, vol.108, pp.54-63, 2003.

R. J. Kim and . Judd, Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?, J Am Coll Cardiol, vol.41, pp.1568-72, 2003.

O. Bruder, A. Wagner, C. J. Jensen, S. Schneider, P. Ong et al., Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.56, pp.875-87, 2010.

I. Olivotto, B. J. Maron, E. Appelbaum, C. J. Harrigan, C. Salton et al., Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy, Am J Cardiol, vol.106, pp.261-268, 2010.

R. Rubinshtein, J. F. Glockner, S. R. Ommen, P. A. Araoz, M. J. Ackerman et al., Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy, Circ Heart Fail, vol.3, pp.51-59, 2010.

B. M. Smith, A. L. Dorfman, S. Yu, M. W. Russell, P. P. Agarwal et al., Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy, Am J Cardiol, vol.113, pp.1234-1243, 2014.

A. S. Adabag, B. J. Maron, E. Appelbaum, C. J. Harrigan, J. L. Buros et al., Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance, J Am Coll Cardiol, vol.51, pp.1369-74, 2008.

M. S. Maron, E. Appelbaum, C. J. Harrigan, J. Buros, C. M. Gibson et al., Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy, Circ Heart Fail, vol.1, pp.184-91, 2008.

Z. Weng, J. Yao, R. H. Chan, J. He, X. Yang et al., Prognostic Value of LGE-CMR in HCM: A Meta-Analysis, JACC Cardiovasc Imaging, vol.9, pp.1392-1402, 2016.

Y. L. Hiemstra, P. Debonnaire, M. Bootsma, E. W. Van-zwet, V. Delgado et al., Global Longitudinal Strain and Left Atrial Volume Index Provide Incremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy, Circ Cardiovasc Imaging, p.10, 2017.

D. Liu, K. Hu, P. Nordbeck, G. Ertl, S. Stork et al., Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy, Eur J Med Res, vol.21, p.21, 2016.

M. Rosca, B. A. Popescu, C. C. Beladan, A. Calin, D. Muraru et al., Left atrial dysfunction as a correlate of heart failure symptoms in hypertrophic cardiomyopathy, J Am Soc Echocardiogr, vol.23, pp.1090-1098, 2010.

A. M. Anwar, O. I. Soliman, A. Nemes, M. L. Geleijnse-&amp;-f, and . Cate, An integrated approach to determine left atrial volume, mass and function in hypertrophic cardiomyopathy by two-dimensional echocardiography, Int J Cardiovasc Imaging, vol.24, pp.45-52, 2008.

P. Debonnaire, E. Joyce, Y. Hiemstra, B. J. Mertens, D. E. Atsma et al., Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation, Circ Arrhythm Electrophysiol, p.10, 2017.

Y. Matsuda, Y. Toma, H. Ogawa, M. Matsuzaki, K. Katayama et al., Importance of left atrial function in patients with myocardial infarction, Circulation, vol.67, pp.566-71, 1983.

D. Y. Leung, A. Boyd, A. A. Ng, C. Chi, and &. L. Thomas, Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications, Am Heart J, vol.156, pp.1056-64, 2008.

V. Sachdev, Y. Shizukuda, C. L. Brenneman, C. W. Birdsall, M. A. Waclawiw et al., Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy, Am Heart J, vol.149, pp.730-736, 2005.

M. A. Losi, S. Betocchi, G. Barbati, V. Parisi, C. G. Tocchetti et al., Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy, J Am Soc Echocardiogr, vol.22, pp.76-81, 2009.

S. Nistri, I. Olivotto, S. Betocchi, M. A. Losi, G. Valsecchi et al., Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy), Am J Cardiol, vol.98, pp.960-965, 2006.

W. I. Yang, C. Y. Shim, Y. J. Kim, S. A. Kim, S. J. Rhee et al., Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy, J Am Soc Echocardiogr, vol.22, pp.1338-1381, 2009.

J. D&apos;hooge, D. Barbosa, H. Gao, P. Claus, D. Prater et al., Imaging (2016) Two-dimensional speckle tracking echocardiography: standardization efforts based on synthetic ultrasound data, Eur Heart J Cardiovasc Imaging, vol.17, pp.693-701

M. S. Maron, Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better? Circ Cardiovasc Imaging, p.10, 2017.